Salient features of medical nanoparticles in biological fluids from an analytical ultracentrifuge
Source abstract
Abstract
From the perspective of future translation, medical, biodegradable nanoparticles (NPs) have been investigated using an analytical ultracentrifuge in fluids of various complexity, including human serum, in the temperature range of 6 to 40 °C, and timescales relevant for a nanomedical targeting and clearance application. These studies provided salient insights into the integrity and degradation aspects of the NPs, imposed by varying solution environmental conditions. This was enabled by selective monitoring of the targeting dye moiety, cell-specifically directing the NPs to the desired location of interest, i.e. considering a future translative in vivo application. Our study provides experimental insights that are believed to be of key importance to gauge the feasibility of such translative applications in terms of (i) compatibility with patient sera, (ii) timescales of targeting success, and (iii) timescales of desired erosion enabling clearance from the target. All such aspects are provided a priori any in vivo implementation.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Microfluidic and Bio-sensing Technologies · Microfluidic and Capillary Electrophoresis Applications · nanoparticles nucleation surface interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Organic and Macromolecular Chemistry (IOMC)
Friedrich Schiller University Jena
07743 Jena
Germany
Jena Center for Soft Matter (JCSM)
SmartDyeLivery GmbH
Jena
Funding
Deutsche Forschungsgemeinschaft · Freistaat Thüringen · European Social Fund
References (21)
Show source-provided references
1. Englert · Prog. Polym. Sci. · 2018 · 87 · 10710.1016/j.progpolymsci.2018.07.005 ↗
2. Farokhzad · Adv. Drug Delivery Rev. · 2006 · 58 · 145610.1016/j.addr.2006.09.011 ↗
3. Freitas Jr. · Nanomedicine · 2005 · 1 · 210.1016/j.nano.2004.11.003 ↗
4. Aguado · Sci. Transl. Med. · 2018 · 10 · eaam864510.1126/scitranslmed.aam8645 ↗
5. Riehemann · Angew. Chem., Int. Ed. · 2009 · 48 · 87210.1002/anie.200802585 ↗
6. Schottler · Angew. Chem., Int. Ed. · 2016 · 55 · 880610.1002/anie.201602233 ↗
7. Weber · Angew. Chem., Int. Ed. · 2019 · 58 · 1278710.1002/anie.201902323 ↗
8. Negwer · Nat. Commun. · 2018 · 9 · 530610.1038/s41467-018-07755-0 ↗
9. Perevyazko · J. Polym. Sci., Part A: Polym. Chem. · 2010 · 48 · 392410.1002/pola.24157 ↗
10. Garrett · J. Raman Spectrosc. · 2012 · 43 · 68110.1002/jrs.3170 ↗
11. Jeevanandam · Beilstein J. Nanotechnol. · 2018 · 9 · 105010.3762/bjnano.9.98 ↗
12. S. Bhatia , Natural Polymer Drug Delivery Systems , Springer International Publishing , Cham , 201610.1007/978-3-319-41129-3 ↗
13. Cinar · Anal. Chem. · 2020 · 92 · 793210.1021/acs.analchem.0c01323 ↗
14. Mehn · J. Nanopart. Res. · 2020 · 22
15. Planken · Nanoscale · 2010 · 2 · 184910.1039/c0nr00215a ↗
16. Walter · Nanoscale · 2016 · 8 · 748410.1039/C5NR08547K ↗
17. R. Witzgall , in Blick in die Wissenschaft , Universitätsverlag Regensburg , Regensburg , 2009 , pp. 28–33
18. Richard · J. Clin. Invest. · 1955 · 34 · 134510.1172/JCI103182 ↗
19. Anderson · Mol. Cell. Proteomics · 2004 · 3 · 31110.1074/mcp.M300127-MCP200 ↗
20. Estrup · Z. Chem. Ind. Kolloide · 1911 · 9 · 25910.1007/BF01476636 ↗
21. Press · Nat. Commun. · 2014 · 5 · 556510.1038/ncomms6565 ↗